still some juice leftstill some juice left still some juice left still some juice left still some juice left
Zinc8 Energy Solutions Inc. CSE: ZAIRSUPERCHARGING UPSTATE NEW YORK TO A BATTERY MANUFACTURING HUB: Senator Chuck Schumer supports Zinc8 expansion plans
Zinc8`s cutting-edge battery technology aligns perfectly with his work to expand battery storage capabilities in the Bipartisan Infrastructure Law.
www.rockstone-research.com
AC is long but needs some volume AC is now bullish as wave 5 of Wolfe has finally completed and formed a diamond reversal pattern. First target is the lid of that corrective channel and if successfully penetrated, the final target is shown in the arrow.
I strongly suggest you purchase in $IBOThis stock has completely shuttered the OTC and contributed to traffic gridlock in the morning rush. I'd make any effort to obtain this stock; therefore, for a favorable trade experience
$NRX.V Outpaces Biotech Peers Following TSX.V Listing The biotech sector is presenting exciting opportunities for investors despite the broader downturn in global equity markets. Many of the best biotech companies and ETFs have both strong drug candidate pipelines in the works as well as winning drugs and therapeutic products already on the market. The COVID-19 pandemic has proven and created massive opportunities for the biotechnology sector as a whole, particularly so around innovative players that are developing therapeutic solutions with disruptive potential.
One new player to the field is Nurexone Biologic (NRX.V), a new listee on the TSXV exchange that is redefining exosome therapeutics for application to traumatic brain and spinal cord injuries. It is creating a platform for biologically-guided ExoTherapy that will be administered minimally invasively to patients who have had catastrophic spinal cord injuries.
Since July 15th, NRX +26% as it attracts new investors and institutional players begin to trade the equity. In comparison, the TSX/SPX composite index charted 6% gains, indicating that NRX far outperformed the market baseline over the course of the summer rally. Relative to sectoral ETFs, Nurexone is also trading strong. IBBQ is +6.9% and XBI +6% over the same timeframe NRX is +26%; it is important to note that over this period, the company did not release any price sensitive announcements that would otherwise account for its significant bullish price movement.
Further, exosome-based equities are one area of the wider biotech industry that has continuously traded robustly despite subpar performance for equity markets this year. Sectoral competitors are mixed bag, with KMPH +4.8% while APTO is down 4.4%. Kodiak Biosciences (KOD) jumped 20%, though it still lags behind NRX's 26% increase. This indicates that as exosome therapeutic developers struggle to maintain forward momentum amidst the backdrop of a challenging macroeconomic landscape, NRX is outperforming both sectoral ETFs and direct competitors. Though its a newby to capital markets, so far Nurexone is standing out as the bullish outlier with LT potential.
GXE long Entered GXE long here. Looking to back test the 236. We've stopped on major MA support. Usual 3 stage stop loss MGMT.
CCO longIts been a while. Lots of hand sitting this month. Finally a few stocks are moving the right direction.
Entry here in CCO Long. Bounced off the long term 0.382. looking for short term run to 0.5. 3/8 trap triggered entry. 1st target of %10 hit so took 1/3 off. Stop moved into slight profit for protection.
Accumulating Uranium stocks at this time so looking at how to hold last 3rd for a long period. Will update plan as it develops.
Ultra low market cap high grade Gold juniorMGI reported high grade Gold intercepts of 3.47 m of 13.90 g/t and 9.30 m of 4.51 g/t and appears to be mispriced at $1.8M market cap. Comparables trade at multiples more.
TMD - STOCK - LONG - ASCENDING TRIANGLETITAN MEDICAL INC. STOCK displays an ascending triangle pattern. Entry is at the breakout of the pattern make sure this coincides with a volume increase to verify breakout.
Exit is shown in the chart (Flag).
The worth of $DIA is growing conspicuously,You've probably considered the keys to success in $DIA stock, so let me clarify this self-definition, transparency, authenticity, and accountability. These factors have contributed to the stock's success.
good signal in SHOP marketwe have good signal idicate that the market is long but we still dont have good confirmation well wait and see what happen next
BBD.B Update idea after splitLONG LONG LONG ! Company have a very good future. The company sold the part that produced the trains. And she concentrated all her attention on the production of business jets. Technically, the company's shares look very cool. We tried to hide the technical specifications behind the split, but I have an old graph in my head.)))
RGDReunion Gold . Gold producer in Africa. Beginning colsolidation phase after break higher. Look for .09 cents.
CRAFTPORT CANADASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
SILVER PREDATOR CANADA Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
THYMBAL RESOURCES CANADASun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series
Focus: Worldwide
By Sun Storm Investment Research & NexGen Wealth Management Service
A Profit & Solutions Strategy & Research
Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures |
USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India
Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision.
#debadipb #profitsolutions
FRFirst Majestic still remains one of my top picks for a true silver bull market which i believe we are in now. Not my top pick, but a close 3rd from the top. So i am overweight in this one for sure. This is the weekly perspective, the monthly is even more bullish showing a giant ascending triangle. I keep adding on any pullback.
Infected MushroomSince selling into the listing day pump (sorry) I've been waiting patiently for $1 MMED.
Daily RSI is now 50+ and showing bullish divergence.
Now that MMED has a new CEO, I have more faith in MMED to deliver useful therapeutics. A more telling bottom signal is the change of CFO; let's hope Mr. "Greenway" lives up to his name :)
mindmed.co
$ISV - Breakout play for +10 to 30% Technical Analysis (TA)
The monthly and weekly was oversold and price pushed higher with significant momentum after a consolidation phase.
Retracement to $25 is expected However, the push to $30 would require catalysts to increase momentum.
We could hit $25 and then come back down or go through another consolidation phase before further upside to $30.
Price Target
Entry: $22-$23
Target 1: $25
Target 2: $30
